API Holdings Ltd IPO

Upcoming DRHP

IPO Synopsis

PharmEasy’s parent company API Holdings filed a DRHP with SEBI for an IPO worth Rs. 6250 crores. The said IPO was filed on 11th November, 2021 and it will raise funds via fresh equity issuance. 

The company is in talks with its bankers to conduct pre-IPO fundraising through private placement for a total amount of Rs. 1250 crores. This will significantly bring down the main issue size. 

API Holdings held a pre-IPO in October 2021 that closed with an over-subscription from the participants. The list of participants includes names like Singapore-based Amansa Capital, US-based hedge fund Janus Henderson and among others. This activity was priced at US $5.4 billion. 

Citigroup Global Markets India, JM Financial Ltd, Kotak Mahindra Capital, Morgan Stanley India and BoFA Securities India are the book running lead managers to the issue.

 

Objective of the issue

The IPO proceeds will be used for the following:
•    to prepay or repay an outstanding debt of Rs 1,929 crore
•    to fund organic growth initiatives aggregating to Rs 1,259 crore
•    to pursue inorganic growth through acquisitions and other strategic initiatives totalling Rs 1,500 crore
•    for general corporate purposes
 

About API Holdings Ltd

API Holding is India’s largest digital healthcare platform (based on GMV of products and services sold for FY21). It operates an integrated, end to end business that aims to provide solutions for healthcare needs of consumers across the following critical stages of providing digital tools and information on illness and wellness, offering teleconsultation, offering diagnostics and radiology tests, and delivering treatment protocols including products and devices.

In 2012, Siddharth Shah, Hardik and Harsh Parekh launched a digital and phone order platform, Dialhealth.com, which offered services like tele-consult, diagnostic lab pick-ups and medical product delivery. Even after offering multiple services only product delivery attracted significant demand, thus offerings other than product delivery were eventually scaled down.

Ascent, founded in 2013, was the solution to the shortcomings of a fragmented supply chain. 

Between 2013 and 2019, Ascent scaled up its distribution presence by acquiring and integrating more than 20 wholesalers across India, and expanded its reach and business.  By December 2018, Ascent had become one of the largest wholesalers of pharmaceutical products in India, and by December 2020, PharmEasy had become the leading online pharmacy in India. Since then, the company has actively invested into its own businesses and undertaken multiple scaled acquisitions of complementary businesses, to enhance capabilities and offerings in digital healthcare for all stakeholders.

The expansive Pan-India supply chain infrastructure includes 82 warehouses, 10,886 warehousing personnel, and cumulative warehousing space of 699,000 sq.ft. This infrastructure currently undertakes 76,000 deliveries daily
 

Particulars (in Rs. Crores)

FY21

FY20

Revenue

2,335.27

667.54

EBITDA

-569.33

-386.21

PAT

-641.34

335.28

EPS (basic in Rs.)

NA

NA

RoNW

-18.50%

-136.14%

 

Particulars (in Rs. Crores)

FY21

FY20

Total Assets

4,905.34

572.48

Share Capital

25.62

0.01

Total Borrowings

0.9

150.72

 

Particulars (in Rs. Crores)

FY21

FY20

Net Operating Cash Flow

(813.68)

(452.02)

Net Investing Cash Flow

4.49

(189.54)

Net Financing Cash Flow

1,019.02

631.63


Key Points of API Holdings Ltd are:

Key Points

  • Strengths

    1. PharmEasy is India's largest digital brand for the sale of pharma products and healthcare services

    2. Retailio assisted with procurement, visibility and transparent pricing for retail pharmacies from wholesalers while Docon added value by bringing in its advanced AI/ML, user-interface design, and advanced computing techniques. 

    3. Through acquiring both synergistic and complementary businesses, the company has successfully consolidated a fragmented market, increased the scale, enhanced our capabilities and expanded into adjacencies

    4. Experienced, Committed and Passionate founding and professional management team

  • Risks

    1. The company operates in an emerging and dynamic digital healthcare industry which has experienced significant growth, high levels of demand, widespread consumer acceptance and market adoption over the past few years, it is still relatively new in the sector.

    2. It’s a fairly new establishment, it has a limited operating history and unpredictable evaluations, hence, the future quarterly and annual results of operations are subject to a number of risks and uncertainties.

    3. As the proprietary technology infrastructure is the key ingredient to the firm’s success, any system interruptions caused by telecommunications failures, computer viruses, hacking will slow down the performance of the platform and adversely affect the profitability of the firm. 

    4. As the company operates in the pharmaceutical sector, there is always an inherent risk of fraud, third party merchants selling unsafe and defective goods, etc. which could lead to the company being held responsible.

How to apply for an IPO?

  • Login to your 5paisa account and select the issue in the current IPO section

  • Enter the number of lots and price at which you wish to apply for

  • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange

  • You will receive a mandate notification to block funds in your UPI app

  • Approve the mandate request on your UPI and funds will be blocked

FAQs

What is the price band of the IPO?

API Holdings IPO details are yet to be announced.

When does the API Holdings issue open and close?

API Holdings IPO details are yet to be announced.

What is the size of API Holdings IPO issue?

The API Holdings IPO issue size is worth Rs. 6250 crores. 

Who are the promoters/key personnels of API Holdings?

Siddharth Shah (Co-founder, MD, CEO), Aditya Puri (Chairman and Non-executive director), Harsh Parekh (Co-founder and Whole-time Director), Dharmil Sheth (Co-Founder, and Whole-time Director), Ashutosh Sharma (Non-Executive Director), Ankur Thadani (Non-Executive Director)

What is the allotment date of API Holding?

API Holdings IPO details are yet to be announced.

What is the API Holdings listing date?

API Holdings IPO details are yet to be announced.

Who are the book runners for API Holdings IPO?

Citigroup Global Markets India, JM Financial Ltd, Kotak Mahindra Capital, Morgan Stanley India and BoFA Securities India are the book running lead managers to the issue.

What is the objective of the issue?

The IPO proceeds used to prepay or repay an outstanding debt of Rs 1,929 crore, fund organic growth initiatives aggregating to Rs 1,259 crore, pursue inorganic growth through acquisitions and other strategic initiatives totalling Rs 1,500 crore, and for general corporate purposes.

How to apply for the API Holdings IPO?

To apply for the IPO, follow the steps given below

  • Login to your 5paisa account and select the issue in the current IPO section
  • Enter the number of lots and price at which you wish to apply for
  • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange
  • You will receive a mandate notification to block funds in your UPI app
Open Demat Account